Eupraxia Pharmaceuticals Inc. Share Price
NASDAQ: EPRXEupraxia Pharmaceuticals Inc. Stock Performance
Eupraxia Pharmaceuticals Inc. Share Price Today
As of 30 October 2026, Eupraxia Pharmaceuticals Inc.'s share price is $7.25. The stock opened at $7.45, compared to its previous close of $7.38. During today's trading session, Eupraxia Pharmaceuticals Inc.'s share price traded between $7.10 and $7.47, with an average price of $7.29. Over the past 52 weeks, the stock has recorded a high of $9.23 and a low of $5.29. In terms of performance, Eupraxia Pharmaceuticals Inc.'s share price has declined by 7.12% over the last six months and is up 35.17% on a year-on-year basis.
Eupraxia Pharmaceuticals Inc. Share Price Chart
Eupraxia Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Eupraxia Pharmaceuticals Inc.
Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs. Currently, the company has two distinct clinical development programs, one targeting EoE and the second targeting chronic Osteoarthritis pain in the knee and has completed a Phase 2b clinical trial with EP-104IAR in knee OA.
Eupraxia Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $9.12 | $7.26 | -20.44% |
Sep 2026 | $6.34 | $9.13 | +23.56% |
Aug 2026 | $6.47 | $7.38 | +15.39% |
Jul 2026 | $6.75 | $6.40 | -2.88% |
Jun 2026 | $6.98 | $6.59 | -7.25% |
May 2026 | $7.89 | $7.11 | -8.91% |
Apr 2026 | $7.59 | $7.80 | +7.59% |
Mar 2026 | $8.34 | $7.25 | -10.99% |
Feb 2026 | $8.20 | $8.14 | -3.50% |
Jan 2026 | $7.58 | $8.44 | +11.13% |
Dec 2025 | $6.36 | $7.59 | +20.94% |
Nov 2025 | $5.75 | $6.28 | +17.16% |